Early Diagnosis and Biomarkers in Dementia

Early diagnosis of dementia is crucial for effective intervention and slowing disease progression. Advances in biomarkers—biological indicators of disease—are enhancing diagnostic accuracy and enabling earlier detection. Biomarkers for dementia include amyloid plaques and tau protein tangles in Alzheimer's disease, detectable through PET scans or cerebrospinal fluid analysis. Additionally, genetic markers, neuroimaging (MRI, fMRI), and blood-based tests are being researched for their potential to identify dementia at its earliest stages. Early detection allows for timely treatment, better management of symptoms, and improved outcomes for patients and caregivers.

    Related Conference of Early Diagnosis and Biomarkers in Dementia

    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    June 22-23, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan

    Early Diagnosis and Biomarkers in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in